Department of Radiology, Saint-Antoine Hospital, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France.
Department of Radiology, Saint-Antoine Hospital, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France.
Diagn Interv Imaging. 2014 Jan;95(1):27-36. doi: 10.1016/j.diii.2013.04.015. Epub 2013 Aug 24.
Hepatocellular carcinoma is the sixth most common cancer throughout the world. It is almost exclusively arterially vascularized, unlike the vascularization of the liver, which has a dual supply with a portal component of 75 to 80% and an arterial component of 20 to 25%. The reference treatment for intermediary stages of the Barcelona (B) classification is hepatic artery chemoembolization. The aim of chemoembolization is to inject the tumor chemotherapy into the artery and then to embolize the artery (or arteries), which supply the tumor. For this, knowledge of the anatomy of the hepatic artery is essential. Approximately 55% of the patients belong to the modal distribution, although numerous anatomical variants exist and must be recognized. In addition, primarily non-hepatic arteries may contribute to the vascularization of some hepatocellular carcinomas. Furthermore, new arterial supplies can be recruited by tumors after surgical or chemoembolization treatments. The aim of this article is to describe the different arteries, which may vascularize hepatocellular carcinomas. These arteries must be looked for, recognized, and reported by the radiologist on cross-section examinations in the pre-treatment assessment.
肝细胞癌是全球第六大常见癌症。它几乎完全是动脉血管化的,与肝脏的血管化不同,肝脏有双重供应,门静脉成分占 75%至 80%,动脉成分占 20%至 25%。巴塞罗那(B)分类中间阶段的参考治疗方法是肝动脉化疗栓塞。化疗栓塞的目的是将肿瘤化疗药物注入动脉,然后栓塞供应肿瘤的动脉(或多条动脉)。为此,必须了解肝动脉的解剖结构。大约 55%的患者属于模态分布,尽管存在许多解剖变异,必须加以识别。此外,主要非肝动脉可能有助于一些肝细胞癌的血管生成。此外,肿瘤在手术或化疗栓塞治疗后可能会招募新的动脉供应。本文的目的是描述可能为肝细胞癌提供血液供应的不同动脉。这些动脉必须在治疗前评估的横断面检查中由放射科医生寻找、识别和报告。